Breast cancer proteomics: clinical perspectives

被引：6
|
作者：
Lau, Thomas Y. K. [1 ]
O'Connor, Darran P. [1 ]
Brennan, Donal J. [1 ]
Duffy, Michael J. [1 ]
Pennington, Stephen R. [1 ]
Gallagher, William M. [1 ]
机构：
[1] Natl Univ Ireland Univ Coll Dublin, Sch Biomol & Biomed Sci, Conway Inst, Dublin 4, Ireland
来源：
EXPERT OPINION ON BIOLOGICAL THERAPY | 2007年 / 7卷 / 02期
关键词：
biomarkers; breast cancer; proteomics; translational research;
D O I：
10.1517/14712598.7.2.209
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Breast cancer is the one of leading causes of cancer-related deaths in women within economically developed regions of the world. A major focus of present research into this malignancy is the identification of new biomarkers and drug targets to improve detection and treatment. Proteomics represents one of the latest technological developments in this context. It aims to analyse the complex circuitry of the breast cancer proteome. Here, the authors review how breast cancer proteomics has progressed so far, with emphasis on its potential application to clinically relevant scenarios.
引用
收藏
页码：209 / 219
页数：11
相关论文
共 50 条
  • [21] Next-Generation Proteomics and Its Application to Clinical Breast Cancer Research
    Mardamshina, Mariya
    Geiger, Tamar
    AMERICAN JOURNAL OF PATHOLOGY, 2017, 187 (10): : 2175 - 2184
  • [22] Clinical and therapeutic perspectives of gene expression profiling for breast cancer
    Chiuri, V. E.
    Leo, G.
    Lorusso, V.
    ANNALS OF ONCOLOGY, 2007, 18 : 58 - 62
  • [23] Breast cancer brain metastases: biology and new clinical perspectives
    Isabell Witzel
    Leticia Oliveira-Ferrer
    Klaus Pantel
    Volkmar Müller
    Harriet Wikman
    Breast Cancer Research, 18
  • [24] Breast cancer brain metastases: biology and new clinical perspectives
    Witzel, Isabell
    Oliveira-Ferrer, Leticia
    Pantel, Klaus
    Mueller, Volkmar
    Wikman, Harriet
    BREAST CANCER RESEARCH, 2016, 18
  • [25] PARP inhibitors in breast cancer: Current clinical development and perspectives
    Robbe, Julie
    Moretta, Jessica
    Vicier, Cecile
    Sabatier, Renaud
    Nogues, Catherine
    Goncalves, Anthony
    BULLETIN DU CANCER, 2020, 107 (10) : 1024 - 1041
  • [26] Clinical Proteomics in Cancer Research
    Lopez, Elena
    Madero, Luis
    Melen, Gustavo J.
    Ramirez, Manuel
    Roukos, Dimitrios H.
    Cho, William C.
    CURRENT PROTEOMICS, 2013, 10 (02) : 179 - 191
  • [27] Implications of Functional Proteomics in Breast Cancer
    Chae, Young Kwang
    Gonzalez-Angulo, Maria
    ONCOLOGIST, 2014, 19 (04): : 328 - 335
  • [28] Proteomics in epigenetics: new perspectives for cancer research
    Bartke, Till
    Borgel, Julie
    DiMaggio, Peter A.
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2013, 12 (03) : 205 - 218
  • [29] Proteomics for Breast Cancer Urine Biomarkers
    Beretov, Julia
    Wasinger, Valerie C.
    Graham, Peter H.
    Millar, Ewan K.
    Kearsley, John H.
    Li, Yong
    ADVANCES IN CLINICAL CHEMISTRY, VOL 63, 2014, 63 : 123 - 167
  • [30] Proteomics of Breast Cancer: Outcomes and Prospects
    El Yazidi-Belkoura, Ikram
    Adriaenssens, Eric
    Vercoutter-Edouart, Anne-Sophie
    Lemoine, Jerome
    Nurcombe, Victor
    Hondermarck, Hubert
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2002, 1 (04) : 287 - 295
12345